机构:[1]Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[2]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China四川大学华西医院[3]Institute of Burn Research, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
National Major Scientific and Technological
Special Project for ‘Significant New Drugs Development’ during the Twelfth
Five-year Plan Period (2012ZX09103101-036) and by a grant from the
National Natural Science Foundation of China (No. 30600648).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类|2 区医学
小类|2 区传染病学2 区微生物学2 区药学
最新[2023]版:
大类|2 区医学
小类|1 区药学2 区传染病学2 区微生物学
第一作者:
第一作者机构:[1]Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Wu Sisi,Yang Tao,Luo Youfu,et al.Efficacy of the novel oxazolidinone compound FYL-67 for preventing biofilm formation by Staphylococcus aureus.[J].The Journal of antimicrobial chemotherapy.2014,69(11):3011-9.doi:10.1093/jac/dku240.
APA:
Wu Sisi,Yang Tao,Luo Youfu,Li Xiaolu,Zhang Xian...&Wang Zhenling.(2014).Efficacy of the novel oxazolidinone compound FYL-67 for preventing biofilm formation by Staphylococcus aureus..The Journal of antimicrobial chemotherapy,69,(11)
MLA:
Wu Sisi,et al."Efficacy of the novel oxazolidinone compound FYL-67 for preventing biofilm formation by Staphylococcus aureus.".The Journal of antimicrobial chemotherapy 69..11(2014):3011-9